Teresa K. Tarrant, MD

Dupilumab was safe and effective in treating a group of six children and young adults with inborn errors of immunity and moderate to severe atopic dermatitis, according to a study published in Pediatric Allergy and Immunology.

Most children with a primary immunodeficiency experienced fatigue, which can be evaluated via a review of these patients’ charts and use of a generic questionnaire, according to a study published in Journal of Clinical Immunology.

Warts, hypogammaglobulinemia, infections and myelokathexis — or WHIM — syndrome is a rare but important primary immunodeficiency that leaves some patients susceptible to life-threatening infections as well as to cancer.